PX1 Research sets the benchmark for KPV COA purity, issuing lot-specific third-party analytical reports for every batch. Synthesized in the USA, our KPV tripeptide undergoes rigorous RP-HPLC purity assessment (≥98%), electrospray mass spectrometry identity confirmation, and LAL endotoxin testing. Orders dispatch same-day Monday through Friday from our California and Arizona facilities.
PX1 Research sets the benchmark for KPV COA purity, issuing lot-specific third-party analytical reports for every batch. Synthesized in the USA, our KPV tripeptide undergoes rigorous RP-HPLC purity assessment (≥98%), electrospray mass spectrometry identity confirmation, and LAL endotoxin testing. Orders dispatch same-day Monday through Friday from our California and Arizona facilities.
PX1 Research enforces strict quality control parameters for every batch of Lysine-Proline-Valine (KPV). Each production lot is verified by independent, ISO/IEC 17025-accredited analytical laboratories to ensure absolute sequence identity, low residual salt content, and chemical purity exceeding 98.0% by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
Unlike vendors who rely on generic manufacturer datasheets, PX1 provides full lot-specific transparency. Researchers can download complete Certificates of Analysis (COAs) featuring full HPLC chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, and Quantitative Chromogenic LAL endotoxin test results matched directly to the batch number printed on their vial.
When you order 10 mg vials of KPV from PX1 Research, you receive a thoroughly audited compound engineered specifically for delicate in vitro and preclinical research applications. You can also explore our complete research catalog to view our full inventory of analytical-grade peptides.
KPV is a naturally occurring C-terminal tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH). In academic literature, it functions as an anti-inflammatory tripeptide that acts independently of melanocortin receptors to influence intracellular signaling cascades. It is actively researched for modulating inflammatory pathways, particularly in intestinal barrier and colitis models where epithelial integrity and cytokine downregulation are primary endpoints.
Because KPV is a short three-amino-acid sequence (Lys-Pro-Val), synthesis precision is paramount. Truncated peptide fragments, incomplete deprotection artifacts, or residual coupling reagents like diisopropylcarbodiimide (DIC) can alter cellular receptor binding or induce non-specific cytotoxicity in cell culture assays. High-purity kpv peptide material ensures that observed bioactivity stems entirely from the intended sequence rather than chemical impurities.
Furthermore, residual counter-ions such as trifluoroacetic acid (TFA) left behind during solid-phase peptide synthesis (SPPS) can depress cell viability if unquantified. PX1 performs rigorous counter-ion exchange and measures net peptide content to ensure reliable, reproducible experimental results across all preclinical models.
A authentic Certificate of Analysis must provide actionable, verifiable chemical data rather than basic pass/fail assertions. When reviewing a PX1 KPV COA, researchers should examine four core analytical sections to confirm compound integrity.
1. Header and Lot Identification: The document header explicitly details the lot number, manufacture date, re-test date, chemical formula (C16H30N4O4), and theoretical molecular weight (342.44 g/mol). This lot number directly matches the laser-etched matrix on the physical vial label.
2. RP-HPLC Chromatographic Trace: The HPLC section displays the elution profile recorded at 214 nm or 220 nm. The main peak represents the target tripeptide, and the integrated peak area percentage indicates overall chemical purity. PX1 mandates a target peak area of ≥98.0%, with zero single unknown impurity peaks exceeding 0.5%.
3. Mass Spectrometry (ESI-MS) Confirmation: The mass spectrum verifies the molecular identity of the compound. The dominant signal corresponds to the monoisotopic mass [M+H]+ peak at 343.2 m/z, confirming that the correct amino acid sequence was synthesized without unexpected modifications.
4. Endotoxin and Peptide Content Analysis: The bottom panel records the Limulus Amebocyte Lysate (LAL) assay results in EU/mg and the net peptide content percentage determined by Amino Acid Analysis (AAA) or total nitrogen analysis.
To guarantee absolute consistency across scientific trials, PX1 subjects every synthesis lot to a multi-tiered analytical stack before clearing the material for distribution.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) isolates the target tripeptide from synthesis side-products, deletion sequences, and residual protecting groups. By running a steep mobile-phase gradient of acetonitrile and water with 0.1% TFA across a C18 analytical column, RP-HPLC resolves even closely eluting diastereomers.
Electrospray Ionization Mass Spectrometry (ESI-MS) provides definitive confirmation of primary molecular structure. By ionizing the sample and analyzing its mass-to-charge ratio, mass spectrometry rules out amino acid substitutions, heavy metal contaminants, or truncated species.
Amino Acid Analysis (AAA) and Nitrogen Content determination establish the precise ratio of pure peptide mass to bound water and counter-ions. Lyophilized peptide cakes inherently retain variable amounts of moisture and acetate or TFA salts; AAA allows researchers to calculate exact molar concentrations when preparing working stock solutions.
Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls—are potent immunostimulants. In studies investigating intestinal epithelial tissue, immune cell activation, or colitis models, endotoxin contamination creates severe experimental artifacts by triggering Toll-like receptor 4 (TLR4) cascades.
A peptide sample with high purity by HPLC can still carry significant endotoxin contamination if processed in unmonitored environments. PX1 utilizes Kinetic Chromogenic LAL assays to quantify endotoxin levels in every batch, establishing a strict threshold of <0.01 EU/mg.
To maintain sterile fill standards, PX1 lyophilizes and seals KPV vials inside ISO Class 5 cleanroom environments. Standardized crimp-top vials equipped with bromobutyl stoppers prevent moisture entry and atmospheric oxidation during transit and long-term storage.
Evaluating research vendors requires assessing verifiable testing methodology, supply chain controls, and analytical documentation. The table below outlines how PX1 Research criteria compare to standard commercial market practices.
Purity Verification: PX1 provides lot-specific RP-HPLC chromatograms with full peak integration data showing ≥98.0% purity for every lot. Standard market vendors often present single static PDF COAs reused across multiple synthesis batches.
Identity Confirmation: PX1 uses high-resolution ESI-MS matching exact target mass on every single batch. Standard vendors frequently omit mass spectra or provide illegible low-resolution scans.
Endotoxin Data: PX1 guarantees quantitative LAL assay reporting (<0.01 EU/mg) on every lot COA. Standard vendors rarely perform LAL testing, introducing risk into cellular signaling assays.
Sourcing and Traceability: PX1 manages USA-based synthesis and domestic ISO 17025 testing with verifiable batch retention. Standard vendors frequently import unverified bulk powders with unknown handling histories.
Fulfillment Speed: PX1 dispatches orders same-day (M–F) from facilities in California and Arizona. Standard vendors rely on drop-shipping or standard 3-5 day processing turnarounds.
When sourcing research peptides for academic or industrial laboratories, identifying low-quality suppliers is critical to protecting experimental validity. Watch for these common red flags during vendor auditing:
Generic or Missing Lot Numbers: If the batch number on the COA does not match the physical label on the vial, the documentation is invalid for that material. Always demand lot-matched documentation.
Missing Baseline Chromatograms: Suppliers who trim chromatogram axes or present cropped HPLC graphs may be masking early-eluting salt peaks or late-eluting hydrophobic impurities.
Absence of Endotoxin Reporting: Suppliers that do not publish LAL assay results expose your cell culture or animal tissue assays to unaccounted inflammatory background noise.
Unusually Low Pricing with No Analytical Proof: Synthesis, purification, and multi-tier third-party analytical testing incur substantial operational costs. Exceptionally cheap peptides typically indicate crude technical-grade material that skipped post-synthesis RP-HPLC purification.
Quality assurance extends beyond the initial release of a product batch. PX1 Research maintains a rigorous sample retention protocol for every manufactured lot of KPV.
A portion of every production lot is stored in our temperature-controlled analytical archive at -20°C. These retained samples undergo periodic stability monitoring and serve as reference standards if a research institution requests secondary verification or longitudinal stability data.
This rigorous traceability model allows investigators conducting multi-month longitudinal studies to request identical batch releases or verify consistency across different experimental phases. Researchers interested in broader compound validation protocols can consult the PX1 research library for technical references.
In preclinical studies examining mucosal integrity, cellular repair, and inflammatory pathway modulation, researchers frequently study KPV alongside complementary peptide sequences.
BPC-157 is widely studied for its interactions with growth factor pathways, extracellular matrix remodeling, and nitric oxide synthesis in gastrointestinal tissue models. Researchers evaluating gut barrier homeostasis can order BPC-157 10 mg alongside KPV to compare differential signaling mechanisms.
Similarly, researchers exploring epithelial tight junction dynamics and paracellular permeability often evaluate compounds within our tight junction research peptides selection. For high-volume institutional protocols or bulk assay development, facilities can apply through the PX1 wholesale peptide portal.
When you buy from PX1 Research, your order is processed with the precision and speed required by active research laboratories.
Each KPV order ships as 10 mg of lyophilized powder packaged in heavy-walled glass vials sealed under an inert argon atmosphere with flip-off aluminum caps. Every shipment includes direct access to the downloadable lot-matched COA covering HPLC purity, ESI-MS identity, and LAL endotoxin metrics.
All orders placed before 3:00 PM EST Monday through Friday dispatch same-day from our dual distribution centers in California and Arizona. Packages are shipped in climate-shielded, insulated packaging via tracked priority transit. Our technical support staff is available to assist research institutions with documentation, batch reservation, and custom delivery logistics. To secure analytical-grade material for your laboratory, buy KPV 10 mg research vials directly from PX1 Research today.
Is a COA provided with every PX1 KPV lot?
Yes. Every single lot of KPV distributed by PX1 Research includes a downloadable, lot-matched Certificate of Analysis containing independent third-party RP-HPLC, ESI-MS, and LAL endotoxin testing data.
What HPLC purity level does PX1 guarantee for KPV?
PX1 Research guarantees a minimum chemical purity of ≥98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) at 214 nm.
How does PX1 test for endotoxins in KPV vials?
We utilize Kinetic Chromogenic Limulus Amebocyte Lysate (LAL) assays on every batch. Each lot must demonstrate an endotoxin level below 0.01 EU/mg to pass quality control.
What is the difference between total mass and net peptide content?
Total mass includes the peptide along with absorbed water weight and counter-ions (like TFA or acetate). Net peptide content measures the actual percentage of pure amino acid sequence within that total mass.
How fast does PX1 Research ship KPV orders?
Orders placed before 3:00 PM EST Monday through Friday ship same-day from our California or Arizona facilities using expedited domestic carrier services with tracking.
Is PX1 KPV synthesized in the United States?
Yes. PX1 Research KPV is synthesized, purified, lyophilized, and analytically verified within United States facilities adhering to strict quality control standards.
What physical form does PX1 KPV ship in?
It ships as a sterile, lyophilized (freeze-dried) white powder sealed in vacuum-stoppered glass vials to ensure optimal structural stability during transit.
How should lyophilized KPV be stored upon delivery?
Lyophilized KPV vials should be stored in a freezer at -20°C for long-term stability. Avoid repeated freeze-thaw cycles after reconstituting in sterile laboratory reagents.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.